Cargando…
Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
RATIONALE: Antiplatelet agents such as aspirin, clopidogrel and dipyridamole are effective in reducing the risk of recurrence after a stroke. Importantly, the risk of recurrence is highest immediately after the index event while antiplatelets cause bleeding. AIMS AND/OR HYPOTHESIS: The ‘Triple Antip...
Autores principales: | Bath, Philip M W, Robson, Katie, Woodhouse, Lisa J, Sprigg, Nikola, Dineen, Robert, Pocock, Stuart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409839/ https://www.ncbi.nlm.nih.gov/pubmed/25640807 http://dx.doi.org/10.1111/ijs.12445 |
Ejemplares similares
-
Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial
por: Bath, Philip M W, et al.
Publicado: (2014) -
Statistical analysis plan for the ‘Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage’ (TICH-2) trial
por: Flaherty, Katie, et al.
Publicado: (2017) -
Safety and efficacy of intensive vs. guideline antiplatelet therapy in high‐risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)
Publicado: (2015) -
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
por: Bath, Philip M, et al.
Publicado: (2018) -
Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure()
por: Woodhouse, Lisa J., et al.
Publicado: (2023)